ohdsi-studies/Covid19DrugRepurposing: Evaluation of the Safety and Efficacy of Existing Drugs Considered for Treatment of COVID-19
Many existing drugs are being considered for use in treatment and prophylaxis of COVID-19 in rapid clinical trials across the world. However, the full safety profiles of these drugs is often unknown, and the current trials are unlikely to be powered or have sufficent follow-up time to evaluate most safety outcomes. The aim of this OHDSI study is to use existing retrospective data to evaluate the safety of these drugs. Where possible, we also attempt to estimate potential efficacy, for example using prior viral infections as surrogate outcome, or where available by using COVID-19 as outcome.
Getting started
Browse package contents
Package details |
|
|---|---|
| Maintainer | Martijn Schuemie <schuemie@ohdsi.org> |
| License | Apache License 2.0 |
| Version | 0.0.1 |
| Package repository | View on GitHub |
| Installation |
Install the latest version of this package by entering the following in R:
|
